Ann joined Brandon Capital in 2008.
Prior to joining Brandon Capital, Ann worked at The University of Melbourne in commercial research management for the Department of Medicine at St Vincent’s Hospital. Ann continues to work with The University in this capacity on a part-time basis.
Ann is currently the Chief Operating Officer of OccuRx and Certa Therapeutics. Previously, she was the Chief Operating Officer of Fibrotech Therapeutics (acquired by Shire in 2014).
Ann has a Bachelor of Psychology and Communications from Monash University and a Masters degree in Applied Positive Psychology from The University of Melbourne.